Bioceres Crop Solutions Corp.

  • Market Cap: Micro Cap
  • Industry: Chemicals & Petrochemicals
  • ISIN: KYG1117K1141
USD
1.58
-0.04 (-2.47%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

180.52 k

Shareholding (Mar 2025)

FII

12.38%

Held by 27 FIIs

DII

85.12%

Held by 4 DIIs

Promoter

0.00%

How big is Bioceres Crop Solutions Corp.?

22-Jun-2025

As of Jun 24, Bioceres Crop Solutions Corp. has a market capitalization of 304.05 million, with net sales of 383.29 million and a net profit of -9.27 million over the latest four quarters. Shareholder's funds are at 304.72 million, and total assets amount to 850.63 million.

As of Jun 18, Bioceres Crop Solutions Corp. has a market capitalization of 304.05 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 24, the sum of Net Sales for the latest four quarters is 383.29 million, while the sum of Net Profit for the same period is -9.27 million.<BR><BR>As of Jun 24, the reporting period shows Shareholder's Funds at 304.72 million and Total Assets at 850.63 million.

Read More

What does Bioceres Crop Solutions Corp. do?

22-Jun-2025

Bioceres Crop Solutions Corp. provides crop productivity solutions in the Chemicals & Petrochemicals industry, with recent net sales of $60 million and a market cap of $304.05 million. The company is currently operating at a loss, with a net profit of -$2 million.

Overview:<BR>Bioceres Crop Solutions Corp. is a provider of crop productivity solutions in the Chemicals & Petrochemicals industry, operating within the micro-cap market.<BR><BR>Financial Snapshot:<BR>- Most recent Net Sales: 60 Million (Quarterly Results - Mar 2025)<BR>- Most recent Net Profit: -2 Million (Quarterly Results - Mar 2025)<BR>- Market-cap: USD 304.05 Million (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: NA (Loss Making)<BR>- Industry P/E: NA<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: 0.84<BR>- Return on Equity: 0.00%<BR>- Price to Book: 0.00<BR><BR>Contact Details:<BR>- Address: Ocampo 210 bis, Predio CCT Rosario, ROSARIO NY: 2000<BR>- Tel: ['54 341 4861100']<BR>- Website: https://biocerescrops.com/

Read More

Should I buy, sell or hold Bioceres Crop Solutions Corp.?

22-Jun-2025

Who are in the management team of Bioceres Crop Solutions Corp.?

22-Jun-2025

As of March 2022, the management team of Bioceres Crop Solutions Corp. includes CEO Federico Trucco, Executive Director Gloria Estrada, and four Non-Executive Independent Directors: Kyle Bransfield, Carlos Camargo de Colon, Ari Freisinger, and Natalia Zang.

As of March 2022, the management team of Bioceres Crop Solutions Corp. includes the following individuals:<BR><BR>- Mr. Federico Trucco, who serves as the Chief Executive Officer and Executive Director.<BR>- Ms. Gloria Estrada, who is an Executive Director.<BR>- Mr. Kyle Bransfield, who is a Non-Executive Independent Director.<BR>- Mr. Carlos Camargo de Colon, who is also a Non-Executive Independent Director.<BR>- Mr. Ari Freisinger, who holds the position of Non-Executive Independent Director.<BR>- Ms. Natalia Zang, who is a Non-Executive Independent Director.<BR><BR>This team comprises a mix of executive and non-executive directors, contributing to the governance and strategic direction of the company.

Read More

Is Bioceres Crop Solutions Corp. overvalued or undervalued?

20-Sep-2025

As of May 21, 2025, Bioceres Crop Solutions Corp. is considered overvalued and risky, with a significant year-to-date stock decline of -70.89% compared to the S&P 500's 12.22% return, indicating a deterioration in its valuation outlook.

As of 21 May 2025, the valuation grade for Bioceres Crop Solutions Corp. has moved from expensive to risky, indicating a significant deterioration in its valuation outlook. The company appears to be overvalued given its current metrics, particularly with an EV to EBITDA ratio of 8.96 and an EV to Sales ratio of 0.86, which suggest that investors are paying a premium relative to its earnings and sales. In comparison, peers such as Oil-Dri Corp. of America, which has a P/E ratio of 25.16, and LSB Industries, Inc., with an EV to EBITDA of 12.51, highlight the relative riskiness of Bioceres's valuation.<BR><BR>The company's stock has underperformed significantly against the S&P 500, with a year-to-date return of -70.89% compared to the index's 12.22%. This stark contrast reinforces the notion that Bioceres is currently overvalued in the market.

Read More

Is Bioceres Crop Solutions Corp. technically bullish or bearish?

20-Sep-2025

As of July 8, 2025, Bioceres Crop Solutions Corp. is in a bearish trend with strong indicators across multiple technical analyses, showing a year-to-date return of -70.89% compared to the S&P 500's 12.22%.

As of 8 July 2025, the technical trend for Bioceres Crop Solutions Corp. has changed from mildly bearish to bearish. The current stance is bearish with strong indicators supporting this view. The MACD is bearish on both weekly and monthly time frames, and the moving averages are also bearish on a daily basis. Additionally, the Bollinger Bands, KST, Dow Theory, and OBV all indicate bearish conditions on both weekly and monthly scales. <BR><BR>In terms of performance, the stock has significantly underperformed compared to the S&P 500 across multiple periods, with a year-to-date return of -70.89% versus the S&P 500's 12.22%, and a one-year return of -79.00% compared to the S&P 500's 17.14%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

With a fall in Net Sales of -44.18%, the company declared Very Negative results in Jun 25

  • The company has declared negative results for the last 5 consecutive quarters
  • NET SALES(Q) At USD 74.4 MM has Fallen at -22.36%
  • ROCE(HY) Lowest at 0%
  • CASH AND EQV(HY) Lowest at USD 39.35 MM
2

Risky -

3

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Chemicals & Petrochemicals

stock-summary
Market cap

USD 173 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.78

stock-summary
Return on Equity

-1.86%

stock-summary
Price to Book

0.58

Revenue and Profits:
Net Sales:
60 Million
(Quarterly Results - Mar 2025)
Net Profit:
-2 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-43.87%
0%
-43.87%
6 Months
-68.4%
0%
-68.4%
1 Year
-76.73%
0%
-76.73%
2 Years
-87.22%
0%
-87.22%
3 Years
-88.18%
0%
-88.18%
4 Years
-88.63%
0%
-88.63%
5 Years
-71.27%
0%
-71.27%

Bioceres Crop Solutions Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
17.04%
EBIT Growth (5y)
-13.02%
EBIT to Interest (avg)
1.71
Debt to EBITDA (avg)
3.86
Net Debt to Equity (avg)
0.78
Sales to Capital Employed (avg)
0.76
Tax Ratio
55.30%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
26.87%
ROCE (avg)
11.30%
ROE (avg)
3.01%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
NA
EV to EBIT
26.18
EV to EBITDA
8.96
EV to Capital Employed
NA
EV to Sales
0.86
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
NA
ROE (Latest)
NA
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 10 Schemes (2.5%)

Foreign Institutions

Held by 27 Foreign Institutions (12.38%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is -44.19% vs 15.33% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is -366.67% vs 109.68% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "59.60",
          "val2": "106.80",
          "chgp": "-44.19%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.20",
          "val2": "13.00",
          "chgp": "-101.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "6.10",
          "val2": "7.40",
          "chgp": "-17.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.50",
          "val2": "-0.70",
          "chgp": "171.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.60",
          "val2": "0.60",
          "chgp": "-366.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-104.90%",
          "val2": "66.60%",
          "chgp": "-17.15%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Jun'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Jun 2024 is 10.82% vs 27.67% in Jun 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Jun 2024 is -68.81% vs 617.95% in Jun 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'24",
        "Jun'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "464.80",
          "val2": "419.40",
          "chgp": "10.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "65.80",
          "val2": "75.80",
          "chgp": "-13.19%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "26.90",
          "val2": "23.80",
          "chgp": "13.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-15.50",
          "val2": "-1.60",
          "chgp": "-868.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "6.30",
          "val2": "20.20",
          "chgp": "-68.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "95.80%",
          "val2": "134.60%",
          "chgp": "-3.88%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQstock-summary
Mar'25
Dec'24
Change(%)
Net Sales
59.60
106.80
-44.19%
Operating Profit (PBDIT) excl Other Income
-0.20
13.00
-101.54%
Interest
6.10
7.40
-17.57%
Exceptional Items
0.50
-0.70
171.43%
Consolidate Net Profit
-1.60
0.60
-366.67%
Operating Profit Margin (Excl OI)
-104.90%
66.60%
-17.15%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2025 is -44.19% vs 15.33% in Dec 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Mar 2025 is -366.67% vs 109.68% in Dec 2024

Annual Results Snapshot (Consolidated) - Jun'24stock-summary
Jun'24
Jun'23
Change(%)
Net Sales
464.80
419.40
10.82%
Operating Profit (PBDIT) excl Other Income
65.80
75.80
-13.19%
Interest
26.90
23.80
13.03%
Exceptional Items
-15.50
-1.60
-868.75%
Consolidate Net Profit
6.30
20.20
-68.81%
Operating Profit Margin (Excl OI)
95.80%
134.60%
-3.88%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Jun 2024 is 10.82% vs 27.67% in Jun 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Jun 2024 is -68.81% vs 617.95% in Jun 2023

stock-summaryCompany CV
About Bioceres Crop Solutions Corp. stock-summary
stock-summary
Bioceres Crop Solutions Corp.
Chemicals & Petrochemicals
Bioceres Crop Solutions Corp, formerly Union Acquisition Corp, is a provider of crop productivity solutions. The Company’s solutions include seeds, seed traits, seed treatments, biologicals, adjuvants and fertilizers. Through its subsidiary Rizobacter, it operates through Brazil and Paraguay. Through the Rizobacter brand, it produces and sells soybean biologicals.
Company Coordinates stock-summary
Company Details
Ocampo 210 bis, Predio CCT Rosario , ROSARIO NY : 2000
stock-summary
Tel: 54 341 4861100
stock-summary
Registrar Details